Gene · 9020
Papers3,446
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,446
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The RNA binding protein Arid5a is an activator of TNF signaling in rheumatoid arthritis. | JCI Insight | 2026 | 41574607 | PubTator, text mining | PubMed |
| NF-κB activation as a pro-survival signal from pharmacological inhibition of pyruvate dehydrogenase kinase 1 in non-small-cell lung carcinoma cell models. | Transl Oncol | 2026 | 41570465 | PubTator, text mining | PubMed |
| Investigation of exercise-mimetic bioactive molecules as modulators of MMP activity and expression in cancer cells. | J Enzyme Inhib Med Chem | 2026 | 41555543 | PubTator, text mining | PubMed |
| Interleukin-9 Regulates NF-kB-Mediated Activation of Astrocytes in Multiple Sclerosis Brain. | Neurol Neuroimmunol Neuroinflamm | 2026 | 41529217 | PubTator, text mining | PubMed |
| Siglec-E deletion alters AT macrophages phenotypes, induces an inflammatory response, and adipogenesis during diet-induced obesity. | Int Immunopharmacol | 2026 | 41343943 | PubTator, text mining | PubMed |
| Serum response factor aggravates acute kidney injury via the NIK/NF-κB signaling in LPS-treated HK-2 cells. | Cytotechnology | 2026 | 41268333 | PubTator, text mining | PubMed |
Pharmacokinetics and molecular-level insights into 5-Methyl-3-(trifluoromethyl)-1H-pyrazole for anticancer action: Spectroscopic profiling, solvent interactions, topological analysis and ADME-QSAR predictions. | Spectrochim Acta A Mol Biomol Spectrosc | 2026 | 40972384 | PubTator, text mining | PubMed |
| A multi-grained symmetric differential equation model for learning protein-ligand binding dynamics. | Nat Commun | 2025 | 41469529 | PubTator, text mining | PubMed |
| Long-term outcome of bone marrow transplantation in NIK deficiency: non-redundant role of non-canonical NF-κB signaling in thymic reconstitution and secondary lymphoid organ development. | Front Immunol | 2025 | 41280889 | PubTator, text mining | PubMed |
| Targeting NF-κB-inducing kinase (NIK) in the non-canonical pathway: Advances in the development of NIK inhibitors. | Bioorg Chem | 2025 | 41260069 | PubTator, text mining | PubMed |
| Cytopathologic and histopathologic characteristics of SMARCB1 deficient neoplasm and correlation with molecular and immunohistochemical findings. | Hum Pathol | 2025 | 41224025 | PubTator, text mining | PubMed |
| Investigating the causal role of cellular senescence-related genes in preeclampsia: a multi-omics Mendelian randomization study with differential expression analysis. | Front Endocrinol (Lausanne) | 2025 | 41220585 | PubTator, text mining | PubMed |
| Understanding the Molecular Toxicity of Metal-Based Nanoparticles Through Nanotoxicomics. | Int J Nanomedicine | 2025 | 41211587 | PubTator, text mining | PubMed |
| MYSM1 promotes lung adenocarcinoma progression via TRAF2/3-mediated activation of MAPK and non-canonical NF-κB pathways. | NPJ Precis Oncol | 2025 | 41162619 | PubTator, text mining | PubMed |
| Decoding the functional roles of circular RNAs linked to NF-κB pathway in carcinogenesis. | Discov Oncol | 2025 | 40996665 | PubTator, text mining | PubMed |
| Ginsenoside Rk2 Provides Multidimensional Relief for Ulcerative Colitis by Improving Intestinal Barrier Function, Reshaping Gut Microbiota, and Regulating Th17/Treg Balance. | J Agric Food Chem | 2025 | 40994145 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to CAR T-Cells and How to Overcome Them. | Methods Protoc | 2025 | 40981226 | PubTator, text mining | PubMed |
| Brazilein Impedes IKK Activation by Disrupting RIPK1 Polyubiquitination, Increasing Apoptotic Susceptibility in Cells with Constitutively Active NF-κB. | Biomol Ther (Seoul) | 2025 | 40968087 | PubTator, text mining | PubMed |
| Latest Updates on Sarcopenia and Cachexia: Insights from the 17th Sarcopenia, Cachexia, and Wasting Disorders Conference. | J Bone Metab | 2025 | 40958542 | PubTator, text mining | PubMed |
| Monocyte/macrophage-derived interleukin-15 mediates the pro-inflammatory phenotype of CD226+ B cells in type 1 diabetes. | EBioMedicine | 2025 | 40957221 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9020/papers?page=3